MARKET

MDCX

MDCX

Medicus Pharma Ltd
NASDAQ
0.3370
+0.0169
+5.28%
Pre Market: 0.3244 -0.0126 -3.74% 07:18 05/15 EDT
OPEN
0.3200
PREV CLOSE
0.3201
HIGH
0.3377
LOW
0.3000
VOLUME
34.58K
TURNOVER
3.50K
52 WEEK HIGH
8.94
52 WEEK LOW
0.2500
MARKET CAP
18.59M
P/E (TTM)
-0.1232
1D
5D
1M
3M
1Y
5Y
1D
Medicus Pharma reports Q1 EPS (31c), consensus (22c)
TipRanks · 13h ago
Medicus Pharma Ltd. GAAP EPS of -$0.31
Seeking Alpha · 15h ago
MEDICUS PHARMA LTD - Q1 2026 NET LOSS PER SHARE $0.31
Reuters · 15h ago
MEDICUS PHARMA REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Reuters · 15h ago
Medicus Pharma Q1 FY26 net loss widens 77.22% to $9.04 million
PUBT · 16h ago
Weekly Report: what happened at MDCX last week (0504-0508)?
Weekly Report · 4d ago
New to The Street Broadcasts Show #752 on Bloomberg Television Featuring Graphene Manufacturing Group (OTCQX:GMGRF), T-REX Acquisition Corp (NASDAQ:TRXA), KITON, and Roadzen (NASDAQ:RDZN)
Barchart · 6d ago
Analysts Are Bullish on Top Healthcare Stocks: Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)
TipRanks · 05/07 18:50
More
About MDCX
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. SkinJect Inc., a wholly owned subsidiary of the Company, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver a chemotherapeutic agent to eradicate tumors cells. It is conducting a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-003) in the United States and Europe. It has also commenced a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-004) in the UAE. Its subsidiary, Antev Limited, is a late clinical stage biotech company, developing Teverelix, a GnRH antagonist, as a first in market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse episodes due to enlarged prostate.

Webull offers Medicus Pharma Ltd stock information, including NASDAQ: MDCX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDCX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDCX stock methods without spending real money on the virtual paper trading platform.